L’artérite à cellules géantes : atteintes neurologiques et contribution des nouvelles modalités d’imagerie au diagnostic

Weyand, 2014, Giant-cell arteritis and polymyalgia rheumatica, N Engl J Med, 371, 50, 10.1056/NEJMcp1214825 Borchers, 2012, Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment, Autoimmun Rev, 11, 10.1016/j.autrev.2012.01.003 Assie, 2011, Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients, Medicine, 90, 40, 10.1097/MD.0b013e318206af16 Ostberg, 1971, Temporal arteritis in a large necropsy series, Ann Rheum Dis, 30, 224, 10.1136/ard.30.3.224 Blockmans, 2006, Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients, Arthritis Rheum, 55, 131, 10.1002/art.21699 Penn, 2003, Giant cell arteritis, Autoimmun Rev, 2, 199, 10.1016/S1568-9972(03)00012-0 Haugeberg, 2000, Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings, J Rheumatol, 27, 2624 Gonzalez-Gay, 2007, Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study, Medicine, 86, 61, 10.1097/md.0b013e31803d1764 Wernick, 1994, Familial giant cells arteritis: report of an HLA-typed sibling pair and a review of the literature, Clin Exp Rheumatol, 12, 63 Gonzalez-Gay, 2003, Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica, Semin Arthritis Rheum, 33, 38, 10.1053/sarh.2002.50025 Duhaut, 1999, Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study, J Rheumatol, 26, 361 Hunder, 2006, The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970, Mayo Clin Proc, 81, 1071, 10.4065/81.8.1071 Cimmino, 1995, Polymyalgia rheumatica and giant cell arteritis, Baillères's Clin Rheumatol, 9, 515, 10.1016/S0950-3579(05)80256-0 Liozon, 1982, Horton's temporal arteritis. Anatomopathologic study using light microscopy. Apropos of 123 temporal biopsies, Rev Med Interne, 3, 295, 10.1016/S0248-8663(82)80036-2 González-Gay, 2001, Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy, Semin Arthritis Rheum, 30, 249, 10.1053/sarh.2001.16650 Lensen, 2016, Extracranial giant cell arteritis: a narrative review, Neth J Med, 74, 182 Brack, 1999, Disease pattern in cranial and large-vessel giant cell arteritis, Arthritis Rheum, 42, 311, 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F Nuenninghoff, 2003, Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years, Arthritis Rheum, 48, 3522, 10.1002/art.11353 Evans, 1995, Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study, Ann Intern Med, 122, 502, 10.7326/0003-4819-122-7-199504010-00004 Klein, 1975, Large artery involvement in giant cell (temporal) arteritis, Ann Intern Med, 83, 806, 10.7326/0003-4819-83-6-806 Prieto-González, 2012, Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CTangiography, Ann Rheum Dis, 71, 1170, 10.1136/annrheumdis-2011-200865 Agard, 2008, Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan, Arthritis Rheum, 59, 670, 10.1002/art.23577 Muratore, 2015, Large-vessel giant cell arteritis: a cohort study, Rheumatology, 54, 463, 10.1093/rheumatology/keu329 Brack, 1999, Disease pattern in cranial and large-vessel giant cell arteritis, Arthritis Rheum, 42, 311, 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F Alegria, 2019, Polymyalgia rheumatica and giant cell arteritis in 2019, Rev Rhum Monogr, 86, 199 Nesher, 2004, Risk factors for cranial ischemic complications in giant cell arteritis, Medicine, 83, 114, 10.1097/01.md.0000119761.27564.c9 Larivière, 2014, Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study, Medicine, 93, e265, 10.1097/MD.0000000000000265 Salvarani, 2006, Giant cell arteritis: Involvement of intracranial arteries, Arthritis Rheum, 55, 985, 10.1002/art.22359 Wilkinson, 1972, The vertebral artery: extracranial and intracranial structure, Arch Neurol, 27, 392, 10.1001/archneur.1972.00490170024004 Hayreh, 1998, Ocular manifestations of giant cell arteritis, Am J Ophthalmol, 125, 509, 10.1016/S0002-9394(99)80192-5 Amiri, 2016, Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study, Rheumatology, 55, 33, 10.1093/rheumatology/kev262 Ungprasert, 2016, Cerebrovascular accident in patients with giant cell arteritis: a systematic review and meta-analysis of cohort studies, Semin Arthritis Rheum, 46, 361, 10.1016/j.semarthrit.2016.07.005 Pariente, 2019, Ischemic stroke in giant-cell arteritis: French retrospective study, J Autoimmun, 99, 48, 10.1016/j.jaut.2019.01.009 Pego-Reigosa, 2004, Predictors of cerebrovascular accidents in giant cell arteritis in a defined population, Clin Exp Rheumatol, 6 Guida, 2014, The thromboembolic risk in giant cell arteritis: a critical review of the literature, Int J Rheumatol, 2014, 806402, 10.1155/2014/806402 Kumar, 2013, Giant cell arteritis presenting as depressed mood and headache in an elderly patient, J Clin Rheumatol, 19, 405, 10.1097/RHU.0b013e3182a701e8 Schmidt, 1997, Color duplex ultrasonography in the diagnosis of temporal arteritis, N Engl J Med, 337, 1336, 10.1056/NEJM199711063371902 Arida, 2010, The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis, BMC Musculoskelet Disord, 11, 44, 10.1186/1471-2474-11-44 Duftner, 2018, Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations, RMD Open, 4, 10.1136/rmdopen-2017-000612 Buttgereit, 2016, Polymyalgia rheumatica and giant cell arteritis: a systematic review, JAMA, 315, 2242, 10.1001/jama.2016.5444 Blockmans, 2018, Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch, Am J Med, 108, 246, 10.1016/S0002-9343(99)00424-6 Bley, 2005, Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging, Arthritis Rheum, 52, 2470, 10.1002/art.21226 Marie, 2009, Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients, Medicine, 88, 182, 10.1097/MD.0b013e3181a68ae2 Berthod, 2018, CT analysis of the aorta in giant-cell arteritis: a case-control study, Eur Radiol, 28, 3676, 10.1007/s00330-018-5311-8 Blockmans, 2011, PET in vasculitis, Ann N Y Acad Sci, 1228, 64, 10.1111/j.1749-6632.2011.06021.x Marie, 2013, Giant cell arteritis and polymyalgia rheumatica: diagnostic criteria, Rev Med Interne, 34, 3676 Besson, 2011, Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis, Eur J Nucl Med Mol Imaging, 38, 1764, 10.1007/s00259-011-1830-0 Dejaco, 2018, EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice, Ann Rheum Dis, 77, 636, 10.1136/annrheumdis-2017-212649 Murchison, 2012, Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis, Am J Ophthalmol, 154, 722, 10.1016/j.ajo.2012.03.045 Seeliger, 2017, Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?, Rheumatology, 56, 1154, 10.1093/rheumatology/kex075